Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
Plasmid quantity:
- 10mg, 50mg, 100mg, 500mg, >1g
Talk to our Expert:
- • Research Grade
- • Endotoxin-Free Grade
- • High Quality (HQ) Grade
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human ANGPT1/AGP1/AGPT ORF/cDNA clone-Lentivirus plasmid (NM_001146)
Cat. No.: pGMLV001231
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human ANGPT1/AGP1/AGPT Lentiviral expression plasmid for ANGPT1 lentivirus packaging, ANGPT1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Datasheet
Go to
Angiopoietin 1/ANGPT1/ANGPT1/AGP1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLV001231 |
| Gene Name | ANGPT1 |
| Accession Number | NM_001146 |
| Gene ID | 284 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 1497 bp |
| Gene Alias | AGP1,AGPT,ANG1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACAGTTTTCCTTTCCTTTGCTTTCCTCGCTGCCATTCTGACTCACATAGGGTGCAGCAATCAGCGCCGAAGTCCAGAAAACAGTGGGAGAAGATATAACCGGATTCAACATGGGCAATGTGCCTACACTTTCATTCTTCCAGAACACGATGGCAACTGTCGTGAGAGTACGACAGACCAGTACAACACAAACGCTCTGCAGAGAGATGCTCCACACGTGGAACCGGATTTCTCTTCCCAGAAACTTCAACATCTGGAACATGTGATGGAAAATTATACTCAGTGGCTGCAAAAACTTGAGAATTACATTGTGGAAAACATGAAGTCGGAGATGGCCCAGATACAGCAGAATGCAGTTCAGAACCACACGGCTACCATGCTGGAGATAGGAACCAGCCTCCTCTCTCAGACTGCAGAGCAGACCAGAAAGCTGACAGATGTTGAGACCCAGGTACTAAATCAAACTTCTCGACTTGAGATACAGCTGCTGGAGAATTCATTATCCACCTACAAGCTAGAGAAGCAACTTCTTCAACAGACAAATGAAATCTTGAAGATCCATGAAAAAAACAGTTTATTAGAACATAAAATCTTAGAAATGGAAGGAAAACACAAGGAAGAGTTGGACACCTTAAAGGAAGAGAAAGAGAACCTTCAAGGCTTGGTTACTCGTCAAACATATATAATCCAGGAGCTGGAAAAGCAATTAAACAGAGCTACCACCAACAACAGTGTCCTTCAGAAGCAGCAACTGGAGCTGATGGACACAGTCCACAACCTTGTCAATCTTTGCACTAAAGAAGGTGTTTTACTAAAGGGAGGAAAAAGAGAGGAAGAGAAACCATTTAGAGACTGTGCAGATGTATATCAAGCTGGTTTTAATAAAAGTGGAATCTACACTATTTATATTAATAATATGCCAGAACCCAAAAAGGTGTTTTGCAATATGGATGTCAATGGGGGAGGTTGGACTGTAATACAACATCGTGAAGATGGAAGTCTAGATTTCCAAAGAGGCTGGAAGGAATATAAAATGGGTTTTGGAAATCCCTCCGGTGAATATTGGCTGGGGAATGAGTTTATTTTTGCCATTACCAGTCAGAGGCAGTACATGCTAAGAATTGAGTTAATGGACTGGGAAGGGAACCGAGCCTATTCACAGTATGACAGATTCCACATAGGAAATGAAAAGCAAAACTATAGGTTGTATTTAAAAGGTCACACTGGGACAGCAGGAAAACAGAGCAGCCTGATCTTACACGGTGCTGATTTCAGCACTAAAGATGCTGATAATGACAACTGTATGTGCAAATGTGCCCTCATGTTAACAGGAGGATGGTGGTTTGATGCTTGTGGCCCCTCCAATCTAAATGGAATGTTCTATACTGCGGGACAAAACCATGGAAAACTGAATGGGATAAAGTGGCACTACTTCAAAGGGCCCAGTTACTCCTTACGTTCCACAACTATGATGATTCGACCTTTAGATTTTTGA |
| ORF Protein Sequence | MTVFLSFAFLAAILTHIGCSNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSSQKLQHLEHVMENYTQWLQKLENYIVENMKSEMAQIQQNAVQNHTATMLEIGTSLLSQTAEQTRKLTDVETQVLNQTSRLEIQLLENSLSTYKLEKQLLQQTNEILKIHEKNSLLEHKILEMEGKHKEELDTLKEEKENLQGLVTRQTYIIQELEKQLNRATTNNSVLQKQQLELMDTVHNLVNLCTKEGVLLKGGKREEEKPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T44141-Ab | Anti-ANGP1/ ANGPT1/ AGP1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T44141-Ag | ANGPT1 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP002711 | Human ANGPT1 Lentivirus plasmid |
| ORF Viral Vector | pGMLP004102 | Human ANGPT1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000665 | Human ANGPT1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV001231 | Human ANGPT1 Lentivirus plasmid |
| ORF Viral Vector | pGMLPm004015 | Human ANGPT1 Lentivirus plasmid |
| ORF Viral Vector | pGMPC000824 | Human ANGPT1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002711 | Human ANGPT1 Lentivirus particle |
| ORF Viral Vector | vGMLP004102 | Human ANGPT1 Lentivirus particle |
| ORF Viral Vector | vGMLV000665 | Human ANGPT1 Lentivirus particle |
| ORF Viral Vector | vGMLV001231 | Human ANGPT1 Lentivirus particle |
| ORF Viral Vector | vGMLPm004015 | Human ANGPT1 Lentivirus particle |
Target information
| Target ID | GM-T44141 |
| Target Name | Angiopoietin 1/ANGPT1 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
284 |
| Gene ID |
100056482 (Equus caballus), 101087130 (Felis catus), 11600 (Mus musculus), 282140 (Bos taurus) 284 (Homo sapiens), 403656 (Canis lupus familiaris), 697017 (Macaca mulatta), 89807 (Rattus norvegicus) |
| Gene Symbols & Synonyms | ANGPT1,Angpt1,Ang1,Ang-1,1110046O21Rik,AGP1,AGPT,ANG1,HAE5,AGPT-1,Agpt,Agpt1 |
| Target Alternative Names | 1110046O21Rik,AGP1,AGPT,AGPT-1,ANG-1,ANG1,ANGPT1,Agpt,Agpt1,Ang-1,Ang1,Angiopoietin 1,Angiopoietin-1,Angpt1,HAE5 |
| Uniprot Accession |
O08538,O18920,O35460,Q15389,Q60FC1
Additional SwissProt Accessions: O08538,O18920,Q15389,Q60FC1,O35460 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | cancer, breast cancer |
| Disease from KEGG | MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Rheumatoid arthritis |
| Gene Ensembl | ENSECAG00000016669, ENSMUSG00000022309, ENSBTAG00000014051, ENSG00000154188, ENSCAFG00845010910, ENSMMUG00000017745 |
| Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.